Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Sglcell Biotech is a specialized biotechnology company focused on providing high-resolution single-cell sequencing and spatial transcriptomics services. Based in Shanghai, the company offers a suite of solutions including single-cell RNA-seq, single-cell TCR/BCR sequencing, and advanced bioinformatics support to academic and pharmaceutical researchers. Their platform enables the detailed characterization of cellular diversity and spatial organization within tissues, facilitating breakthroughs in oncology, immunology, and regenerative medicine. Sglcell Biotech aims to lower the barrier for complex genomic studies through standardized workflows and expert data interpretation. The company serves as a critical partner for researchers looking to map the cellular landscape of diseases at unprecedented resolution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Sglcell Biotech.